Medtech Insight is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Morningside Group was the sole investor in Kona Medical Inc.’s $10mm Series D venture round. The funds will be used to market Kona’s Surround Sound renal denervation system in China. The product uses ultrasound to treat nerves leading to and from the kidney, ultimately lowering blood pressure in drug-resistant hypertension patients.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?